Clinical Trial Update: A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS) [Phase 4]

View source ↗

Summary

Phase 4 trial update of epoetin beta in anemic participants with myelodysplastic syndromes completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• epoetin beta (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Myelodysplastic Syndromes | Phase 4 | Status: COMPLETED | Results posted: 2020-04-24